1 t rabbits were each injected with 5 units of
Botox.
2 ceptor for clostridial neurotoxins including
Botox.
3 79% received Botox or bag dilation: 52% had
Botox,
59% underwent dilation, and 36% had both.
4 chalasia, 21 with pneumatic dilation, 1 with
BOTOX,
6 with balloon and BOTOX, and 2 with transthoraci
5 antly more likely to respond to any therapy (
BoTox [
71%], pneumatic dilation [91%], or Heller myotomy
6 eral drug administration approved the use of
Botox (
Allergan, Irvine, CA) for glabellar furrows.
7 le agent in cosmetic applications (including
Botox and Dysport).
8 Furthermore, botulinum toxin (
Botox)
and a dietary fatty acid that modulates PIEZO2 ac
9 n, 23 had been treated with botulinum toxin (
Botox),
and 4 had undergone prior myotomy.
10 c dilation, 1 with BOTOX, 6 with balloon and
BOTOX,
and 2 with transthoracic cardiomyotomy.
11 ed ~8 weeks, for as long as the half-life of
Botox as reported in prior rodent studies.
12 s atrophy after intramuscular injection with
Botox,
extraocular muscles (EOMs) do not.
13 patients required surgery for anal fissure (
Botox +/-
fissurectomy 8; LIS 6).
14 were receiving preparations of neurotoxin A (
BOTOX)
for the treatment of spastic disorders.
15 Botox has recently been shown to be an effective interme
16 ulinum neurotoxin (available commercially as
BOTOX)
has been used successfully for treatment of sever
17 ys to maximize the clinical effectiveness of
Botox in patients with strabismus.
18 Botox-
induced EOM paralysis resulted in a significant sh
19 In this study, the effect of
Botox-
induced muscle paralysis on myofiber remodeling in
20 Of these, 154 had undergone either
Botox injection and/or pneumatic dilation preoperatively
21 myonuclei was significantly increased after
Botox injection in EOMs.
22 protein synthesis becomes upregulated after
Botox injection, and this, in turn, may help explain the
23 nimal effects on myofiber size in EOMs after
Botox injection.
24 Pneumatic dilatation and botulinum toxin (
BOTOX)
injection of the lower esophageal sphincter large
25 Newer therapies, including
Botox injections and new or broadened indications for ex
26 programs for treating dysfunctional voiding,
Botox injections for overactive bladder and an adult ant
27 nd the rate of song recovery after syringeal
Botox injections were correlated with the number of new
28 Six patients had prior dilations or
Botox injections.
29 es to nerve blocks and Onabotulinum toxin A (
Botox)
injections.
30 Our data demonstrate that injection of
Botox into the proximal intestinal wall of diet-induced
31 BOTOX is manufactured with the purified native 900-kDa t
32 Botulinum toxin A (
Botox)
is commonly used for strabismus treatment.
33 Understanding the effect of
Botox on satellite cell activation and myonuclear additi
34 referred for surgery (100 dilation only, 33
Botox only, 21 both).
35 Before myotomy, 79% received
Botox or bag dilation: 52% had Botox, 59% underwent dila
36 Intramuscular injection of
Botox resulted in a significant increase in both the num
37 cious even after failures of dilation and/or
Botox therapy.
38 In
Botox-
treated EOMs, an increased number of myofibers pos
39 ) was administered for various periods after
Botox treatment, followed by various BrdU-free periods.
40 y manipulating syringeal muscle control with
Botox,
which produces a transient partial paralysis.
41 based on Clostridium botulinum neurotoxin A,
Botox,
which we engineered to travel retrogradely betwee